← Open Payments lookup

ERICA LEE: Open Payments

NPI 1013506740 · FULLERTON, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,509 in 75 payments from 18 companies in 2025. Trend: 2023 $1,323 · 2024 $1,649 · 2025 $1,509

Food & beverage: $1,509
CompanyPaymentsAmount
Ardelyx, Inc.13$259
Janssen Biotech, Inc.12$254
Salix Pharmaceuticals, a division of Bausch Health US, LLC9$160
Lilly USA, LLC9$156
GENZYME CORPORATION6$150
Gilead Sciences, Inc.5$120
Intercept Pharmaceuticals, Inc.5$84
Ipsen Biopharmaceuticals, Inc2$67
Fresenius Kabi USA, LLC2$64
Madrigal Pharmaceuticals2$36

Products named: IBSRELA, TREMFYA, XIFAXAN, DUPIXENT, OCALIVA, IQIRVO, OMVOH, REZDIFFRA.

Industry payments across CA — which companies pay providers there.